SELE and ovarian cancer: Using the steric hindrance effect of macromolecules in the nanoparticle, the drug was delivered to the target site through the binding of ESBP to the E-selectin, and a higher therapeutic concentration can be achieved in ovarian cancer cells, thus having a better inhibition in ovarian cancer cells.